These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2598186)

  • 1. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.
    Yurochko AD; Nagarkatti PS; Nagarkatti M; Elgert KD
    Cancer Immunol Immunother; 1989; 30(3):170-6. PubMed ID: 2598186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
    Alleva DG; Burger CJ; Elgert KD
    Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
    Garner RE; Malick AP; Elgert KD
    J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
    Askew D; Yurochko AD; Burger CJ; Elgert KD
    Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
    Yurochko AD; Askew D; Burger CJ; Elgert KD
    Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ; Conroy JM; Elgert KD
    Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules.
    Walker TM; Yurochko AD; Burger CJ; Elgert KD
    J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
    Askew D; Burger CJ; Elgert KD
    Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes.
    Garner RE; Elgert KD
    J Leukoc Biol; 1986 Dec; 40(6):709-24. PubMed ID: 3537182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
    Yurochko AD; Burger CJ; Elgert KD
    Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.